Abstract
Embryonic stem cells, or induced pluripotent cells derived from somatic cells, can yield differentiated progeny with potential applicability for tissue repair. This chapter describes the generation of embryonic stem cells from gamete-derived uniparental embryos. These embryonic stem cells can be patient-derived and potentially histocompatible with the gamete donor. The production of uniparental embryos followed by derivation of embryonic stem cells can be accomplished without producing fertilized zygotes, an advantage that avoids some ethical issues. We describe methods for the generation of uniparental embryonic stem cells from mouse uniparental embryos. We also address evaluation of the integrity of the lines generated, an essential criterion in interpreting differentiation assays in vivo and in vitro.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Shufaro Y, Reubinoff BE. Therapeutic applications of embryonic stem cells. Best Pract Res Clin Obstet Gynaecol 2004;18:909–27.
Keller G. Embryonic stem cell differentiation: emergence of a new era in biology and medicine. Genes Dev 2005;19:1129–55.
Zeng X, Rao MS. Human embryonic stem cells: long term stability, absence of senescence and a potential cell source for neural replacement. Neuroscience 2007;145:1348–58.
Kaufman DS, Thomson JA. Human ES cells—haematopoiesis and transplantation strategies. J Anat 2002;200:243–8.
Boyd AS, Higashi Y, Wood KJ. Transplanting stem cells: potential targets for immune attack. Modulating the immune response against embryonic stem cell transplantation. Adv Drug Deliv Rev 2005;57:1944–69.
Drukker M. Immunogenicity of human embryonic stem cells: can we achieve tolerance?. Springer Semin Immunopathol 2004;26:201–13.
Taylor CJ, Bolton EM, Pocock S, Sharples LD, Pedersen RA, Bradley JA. Banking on human embryonic stem cells: estimating the number of donor cell lines needed for HLA matching. Lancet 2005;366:2019–25.
Cibelli JB, Grant KA, Chapman KB, et alet al. Parthenogenetic stem cells in nonhuman primates. Science 2002;295:819.
Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006;126:663–76.
Barton SC, Surani MA, Norris ML. Role of paternal and maternal genomes in mouse development. Nature 1984;311:374–6.
McGrath J, Solter D. Completion of mouse embryogenesis requires both the maternal and paternal genomes. Cell 1984;37:179–83.
Mann JR, Gadi I, Harbison ML, Abbondanzo SJ, Stewart CL. Androgenetic mouse embryonic stem cells are pluripotent and cause skeletal defects in chimeras: implications for genetic imprinting. Cell 1990;62:251–60.
Robertson EJ, Kaufman MH, Bradley A, Evans MJ. Isolation, properties, and karyotype analysis of pluripotential (EK) cell lines from normal and parthenogenetic embryos. In: Silver LM, Martin GR, Strickland S, editors. Teratocarcinomal Stem Cells Cold Spring Harbor Conferences on Cell Proliferation, 1983, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 1983:647–63.
McLaughlin KJ, Kochanowski H, Solter D, Schwarzkopf G, Szabo PE, Mann JR. Roles of the imprinted gene Igf2 and paternal duplication of distal chromosome 7 in the perinatal abnormalities of androgenetic mouse chimeras. Development 1997;124:4897–904.
Kim K, Lerou P, Yabuuchi A, et alet al. Histocompatible embryonic stem cells by parthenogenesis. Science 2007;315:482–6.
Marchant J. Human eggs supply ‘ethical’ stem cells. Nature 2006;441:1038.
Revazova ES, Turovets NA, Kochetkova OD, et alet al. Patient-specific stem cell lines derived from human parthenogenetic blastocysts. Cloning Stem Cells 2007;9:432–49.
Lin G, OuYang Q, Zhou X, et alet al. A highly homozygous and parthenogenetic human embryonic stem cell line derived from a one-pronuclear oocyte following in vitro fertilization procedure. Cell Res 2007;17:999–1007.
Mai Q, Yu Y, Li T, et alet al. Derivation of human embryonic stem cell lines from parthenogenetic blastocysts. Cell Res 2007;17:1008–19.
Revazova ES, Turovets NA, Kochetkova OD, et alet al. HLA homozygous stem cell lines derived from human parthenogenetic blastocysts. Cloning Stem Cells 2008;10:11–24.
Mutter GL. Role of imprinting in abnormal human development. Mutat Res 1997;396:141–7.
Daley GQ, Ahrlund Richter L, Auerbach JM, et alet al. Ethics. The ISSCR guidelines for human embryonic stem cell research. Science 2007;315:603–4.
Hipp J, Atala A. Tissue engineering, stem cells, cloning, and parthenogenesis: new paradigms for therapy. J Exp Clin Assist Reprod 2004;1:3.
Jaenisch R. Human cloning—the science and ethics of nuclear transplantation. N Engl J Med 2004;351:2787–91.
McGrath J, Solter D. Nuclear transplantation in the mouse embryo by microsurgery and cell fusion. Science 1983;220:1300–2.
Surani MA, Barton SC. Development of gynogenetic eggs in the mouse: implications for parthenogenetic embryos. Science 1983;222:1034–6.
Kono T, Obata Y, Wu Q, et alet al. Birth of parthenogenetic mice that can develop to adulthood. Nature 2004;428:860–4.
Kawahara M, Wu Q, Takahashi N, et alet al. High-frequency generation of viable mice from engineered bi-maternal embryos. Nat Biotechnol 2007;25:1045–50.
Lagutina I, Lazzari G, Duchi R, Galli C. Developmental potential of bovine androgenetic and parthenogenetic embryos: a comparative study. Biol Reprod 2004;70:400–5.
Kono T, Sotomaru Y, Sato Y, Nakahara T. Development of androgenetic mouse embryos produced by in vitro fertilization of enucleated oocytes. Mol Reprod Dev 1993;34:43–6.
Kaufman MH, Barton SC, Surani MA. Normal postimplantation development of mouse parthenogenetic embryos to the forelimb bud stage. Nature 1977;265:53–5.
Bartolomei MS, Tilghman SM. Genomic imprinting in mammals. Annu Rev Genet 1997;31:493–525.
Barton SC, Ferguson-Smith AC, Fundele R, Surani MA. Influence of paternally imprinted genes on development. Development 1991;113:679–87.
Fundele RH, Norris ML, Barton SC, et alet al. Temporal and spatial selection against parthenogenetic cells during development of fetal chimeras. Development 1990;108:203–11.
Fundele R, Barton SC, Christ B, Krause R, Surani MA. Distribution of androgenetic cells in fetal mouse chimeras. Roux’s Arch Dev Biol 1995;204:484–93.
Nagy A, Sass M, Markkula M. Systematic non-uniform distribution of parthenogenetic cells in adult mouse chimaeras. Development 1989;106:321–4.
Paldi A, Nagy A, Markkula M, Barna I, Dezso L. Postnatal development of parthenogenetic in equilibrium with fertilized mouse aggregation chimeras. Development 1989;105:115–8.
Fundele R, Norris ML, Barton SC, Reik W, Surani MA. Systematic elimination of parthenogenetic cells in mouse chimeras. Development 1989;106:29–35.
Mann JR, Stewart CL. Development to term of mouse androgenetic aggregation chimeras. Development 1991;113:1325–33.
Hernandez L, Kozlov S, Piras G, Stewart CL. Paternal and maternal genomes confer opposite effects on proliferation, cell-cycle length, senescence, and tumor formation. Proc Natl Acad Sci U S A 2003;100:13344–9.
Jagerbauer EM, Fraser A, Herbst EW, Kothary R, Fundele R. Parthenogenetic stem cells in postnatal mouse chimeras. Development 1992;116:95–102.
Eggenschwiler J, Ludwig T, Fisher P, Leighton PA, Tilghman SM, Efstratiadis A. Mouse mutant embryos overexpressing IGF-II exhibit phenotypic features of the Beckwith–Wiedemann and Simpson–Golabi–Behmel syndromes. Genes Dev 1997;11:3128–42.
Narasimha M, Barton SC, Surani MA. The role of the paternal genome in the development of the mouse germ line. Curr Biol 1997;7:881–4.
Burns JL, Jackson DA, Hassan AB. A view through the clouds of imprinting. FASEB J 2001;15:1694–703.
Eckardt S, Leu NA, Bradley HL, Kato H, Bunting KD, Mclaughlin KJ. Hematopoietic reconstitution with androgenetic and gynogenetic stem cells. Genes Dev 2007;21:409–19.
Kyba M, Perlingeiro RC, Daley GQ. HoxB4 confers definitive lymphoid–myeloid engraftment potential on embryonic stem cell and yolk sac hematopoietic progenitors. Cell 2002;109:29–37.
Rideout WM, Hochedlinger K, Kyba M, Daley GQ, Jaenisch R. Correction of a genetic defect by nuclear transplantation and combined cell and gene therapy. Cell 2002;109:17–27.
Mann JR. Properties of androgenetic and parthenogenetic mouse embryonic stem cell lines; are genetic imprints conserved.? Semin Dev Biol 1992;3:77–85.
Allen ND, Barton SC, Hilton K, Norris ML, Surani MA. A functional analysis of imprinting in parthenogenetic embryonic stem cells. Development 1994;120:1473–82.
Szabo P, Mann JR. Expression and methylation of imprinted genes during in vitro differentiation of mouse parthenogenetic and androgenetic embryonic stem cell lines. Development 1994;120:1651–60.
Dean W, Bowden L, Aitchison A, et alet al. Altered imprinted gene methylation and expression in completely ES cell-derived mouse fetuses: association with aberrant phenotypes. Development 1998;125:2273–82.
Humpherys D, Eggan K, Akutsu H, et alet al. Epigenetic instability in ES cells and cloned mice. Science 2001;293:95–7.
Sturm KS, Berger CN, Zhou SX, Dunwoodie SL, Tan S, Tam PP. Unrestricted lineage differentiation of parthenogenetic ES cells. Dev Genes Evol 1997;206:377–88.
Jiang H, Sun B, Wang W, et alet al. Activation of paternally expressed imprinted genes in newly derived germline-competent mouse parthenogenetic embryonic stem cell lines. Cell Res 2007;17:792–803.
Horii T, Kimura M, Morita S, Nagao Y, Hatada I. Loss of genomic imprinting in mouse parthenogenetic embryonic stem cells. Stem Cells 2008;26:79–88.
Nagy A, Gertsenstein M, Vintersten K, Behringer R. Manipulating the Mouse Embryo, Third ed., Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 2003.
Wassarman PM, DePamphilis ML, editors. Guide to Techniques in Mouse Development, Academic Press, Inc., San Diego, CA, 1993.
Mann JR. Deriving and propagating mouse embryonic stem cell lines for studying genomic imprinting. Methods Mol Biol 2001;181:21–39.
Okabe M, Ikawa M, Kominami K, Nakanishi T, Nishimune Y. ‘Green mice’ as a source of ubiquitous green cells. FEBS Lett 1997;407:313–9.
McLaughlin KJ. Production of tetraploid embryos by electrofusion. Methods Enzymol 1993;225:919–30.
Abbondanzo SJ, Gadi I, Stewart CL. Derivation of embryonic stem cell lines. Methods Enzymol 1993;225:803–23.
Kim K, Ng K, Rugg-Gunn PJ, et alet al. Recombination signatures distinguish embryonic stem cells derived by parthenogenesis and somatic cell nuclear transfer. Cell Stem Cell 2007;1(3):346–52.
Stewart CL. Production of chimeras between embryonic stem cells and embryos. Methods Enzymol 1993;225:823–55.
Mann JR. Surgical techniques in production of transgenic mice. Methods Enzymol 1993;225:782–93.
Nagy A, Rossant J.Production of completely ES cell derived fetuses. In: Joyner AL, editor. Gene Targeting, First ed., IRL, Oxford;1993:147–78.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Humana Press, a part of Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Eckardt, S., McLaughlin, K.J. (2009). Production of Uniparental Embryonic Stem Cell Lines. In: Baharvand, H. (eds) Trends in Stem Cell Biology and Technology. Humana Press. https://doi.org/10.1007/978-1-60327-905-5_2
Download citation
DOI: https://doi.org/10.1007/978-1-60327-905-5_2
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-60327-904-8
Online ISBN: 978-1-60327-905-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)